Copyright
©The Author(s) 2025.
World J Diabetes. Aug 15, 2025; 16(8): 105228
Published online Aug 15, 2025. doi: 10.4239/wjd.v16.i8.105228
Published online Aug 15, 2025. doi: 10.4239/wjd.v16.i8.105228
Figure 6 Downregulation of farnesoid X receptor expression in diabetic nephropathy mouse kidney tissue, changes in serum biochemical indicators of mice after farnesoid X receptor agonist intervention.
A: Immunohistochemical staining detection of farnesoid X receptor expression in renal tissue of db/db mice at different weeks of age compared to db/m; B: Changes in blood creatinine levels in db/m and db/db mice at different weeks of age; C-E: Changes in urinary and serum biochemical indicators in db/db mice treated with obeticholic acid. NC: Negative control; INT-747: Obeticholic acid; Scr: Serum creatinine; UACR: Urine albumin-to-creatinine ratio; CR: Creatinine; BUN: Blood urea nitrogen.
- Citation: Tang JY, Chong YJ, Yang L, Li X, Yang Y, Li JC, Mu J. Activation of farnesoid X receptor upregulates binding immunoglobulin protein expression and alleviates diabetic nephropathy. World J Diabetes 2025; 16(8): 105228
- URL: https://www.wjgnet.com/1948-9358/full/v16/i8/105228.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i8.105228